Pfizer Says 3-Dose COVID-19 Vaccine Is Effective For Children Under 5

Pfizer's three-dose vaccine is reported to be 80% effective against the Omicron variant in children aged six months to five years. Kaiser has released preliminary data and plans to submit it to regulators, pending FDA authorization. The vaccine dosage for this age group is one-tenth of the adult dose.

What new insight or understanding did you gain from this video?